Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:39:06.310Z.
Calculation as of: 2026-10-06T22:39:06.310Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cf9736c803d76d66c79e1885a68840785ad6b55ce886a17ac328e1a4bc30d25a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Vera Therapeutics, Inc.
Market Cap
$2.11B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.11B
Operating Cash Flow Yield
7.69%
TTM Avg
6.35%
3Y Avg
6.23%
5Y Avg
5.99%
Market Cap
$2.11B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.13B
Operating Cash Flow Yield
N/A
TTM Avg
0.97%
3Y Avg
0.97%
5Y Avg
0.97%
Market Cap
$2.06B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.06B
Operating Cash Flow Yield
N/A
TTM Avg
13.24%
3Y Avg
20.26%
5Y Avg
21.41%
Market Cap
$2.17B
Operating Cash Flow Yield
N/A
TTM Avg
3.25%
3Y Avg
15.72%
5Y Avg
12.59%
Market Cap
$2.05B
Operating Cash Flow Yield
3.40%
TTM Avg
3.04%
3Y Avg
2.35%
5Y Avg
2.06%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | $2.11B | N/A | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 7.69% | 6.35% | 6.23% | 5.99% |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | N/A | N/A | N/A | N/A |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | N/A | 0.97% | 0.97% | 0.97% |
| Alvotech (ALVO)vs › | $2.08B | N/A | N/A | N/A | N/A |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | N/A | 13.24% | 20.26% | 21.41% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | N/A | 3.25% | 15.72% | 12.59% |
| Vericel Corporation (VCEL)vs › | $2.05B | 3.40% | 3.04% | 2.35% | 2.06% |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
